baxter international inc (BAX:New York)
Robert M. Davis
Chief Financial Officer and Executive Vice President, Merck & Co. Inc.
|Age||Total Calculated Compensation||This person is connected to 131 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Mr. Robert M. Davis, also known as Rob, has been Chief Financial Officer and Executive Vice President of Merck & Co. Inc. since April 23, 2014. Mr. Davis served as Corporate Vice President at Baxter International Inc. from May 17, 2006 to March 27, 2014 and also served as its President of Medical Products from October 2010 to March 27, 2014. Mr. Davis served as the President of Renal at Baxter International Inc. from July 5, 2010 to October 2010. He served as the Chief ...
One Baxter ParkwayPhone: 224-948-2000
Deerfield, Illinois 60015
Board Members Memberships*
Northwestern University School of Law
J.L. Kellogg School of Management, Northwestern University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Inge G. Thulin||Chairman, Chief Executive Officer and President|
|Irene B. Rosenfeld||Chairman and Chief Executive Officer|
Mondelez International, Inc.
|Jean-Paul Agon||Chairman, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee|
|€3.9M||Compensation as of Fiscal Year 2013.|